Glucosamine HCl reduces equine articular cartilage degradation in explant culture

Osteoarthritis and Cartilage

Volumn 8, Issue 4, 2000, Pages 258-265

  Fenton, J I ^a   Chlebek Brown, K A ^a   Peters, T L ^a   Caron, J P ^a   Orth, M W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Articular cartilage; Equine; Glucosamine; Osteoarthritis

Indexed keywords

GLUCOSAMINE; GLUCOSAMINE DERIVATIVE;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; DRUG EFFECT; DRUG MECHANISM; HORSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL;

EID: 0033858339     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1999.0299     Document Type: Article

References (45)

1. Guccione A, Felson D, Anderson J. The effects of specific medical conditions on functional limitations of elders in the Framingham Study. Am J Public Health. 84:1994;351-358.
2. Yelin E. The economics of osteoarthritis. Brandt KDM, Lohmander LS. Osteoarthritis. 1998;23-30 Oxford University Press, New York.
3. Radin E, Rose R. The role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop. 213:1986;34-40.
4. Donohue J, Buss D, Oegema T, Thompson R. The effect of indirect blunt trauma on adult canine articular cartilage. J Bone Joint Surg. 65:1983;948-957.
5. Radin E, Martin R, Burr D. Effects of mechanical loading on the tissue of the rabbit knee. J Orthop Res. 2:1984;221-234.
6. Radin E, Burr D, Caterson B. Mechanical determinants of osteoarthritis. Seminars Arthritis Rheum. 21:1991;12-21.
7. Johnson L, Radin E. Joint remodeling as a basis for osteoarthritis. Vet Med Assoc. 141:1962;1237-1241.
8. Sokoloff L. Osteoarthritis as a remodeling process. J Rheumatol. 14:1987;7-10.
9. Erlich M, Houles P, Bigliani G, Mankin H. Correlation between articular cartilage collagenase activity in osteoarthritis. Arthritis Rheum. 21:1978;761-765.
10. Yamanda H, Nakagawa T, Stephens RYN. Proteinases and their inhibitors in normal and osteoarthritic articular cartilage. Biomed Res. 8:1987;289-300.
11. Mankin H, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg. 53:1971;523-537.
12. Vasan N. Proteoglycans in normal and severely osteoarthritic human cartilage. Biochem J. 187:1980;781-787.
13. Sweet M, Thonar E, Immelman A, Solomon L. Biochemical changes in progressive osteoarthritis. Ann Rheum Dis. 36:1977;387-398.
14. McDevitt C, Pahl J, Ayad S, Miller R, Uratsuji M, Andrish J. Experimental osteoarthritic articular cartilage is enriched in guanidine soluble type VI collagen. Biochem Biophys Res Commun. 157:1988;250-255.
15. Dodge G, Poole A. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilage and in explants of bovine articular cartilage cultures with interleukin 1. J Clin Invest. 83:1989;647-661.
16. Kempson G. The mechanical properties of articular cartilage. Joints and Synovial Fluid, Vol. 2. 1980;Academic Press, New York. p. 238-9.
17. Mankin H, Johnson M, Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. III. Distribution and metabolism of amino sugar-containing molecules. J Bone Joint Surg. 63:1981;131-139.
18. Tyler J. Articular cartilage cultured with catabolin (pig interleukin-1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J. 227:1985;77-84.
19. Pelletier J, Mineau F, Ranger P, Tardif G, Martel Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage. 4:1996;77-84.
20. Hauselmann H, Oppliger L, Michael B, Stefanovic-Racic M, Evans C. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate cultures. FEBS Lett. 352:1994;361-364.
21. Taskiran D, Stefanovic-Racic M, Georgescu M, Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Comm. 200:1994;142-148.
22. Murrell G, Jang D, Williams R. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Comm. 206:1995;15-21.
23. Frean S, Bryant C, Froling I, Elliott J, Lees P. Nitric oxide production by equine articular cells in vitro. Equine Vet J. 29:1997;98-102.
24. McCarthy M. The neglect of glucosamine for the treatment of osteoarthritis - a personal perspective. Med Hypotheses. 42:1989;323-327.
25. Rovati L. Clinical research in osteoarthritis: design and results of short-term and long-term trials with disease-modifying drugs. Int J Tissue React (Switzerland). 14:1992;243-251.
26. Vaz A. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthritis of the knee in out-patients. Curr Med Res Opin. 8:1982;145-149.
27. Pujalte J, Llavore E, Ylescupidez F. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis. Curr Med Res Opin. 7:1980;110-114.
28. Hanson R, Smalley L, Huff H, White S, Hammad T. Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine Pract. 9:1997;16-22.
29. Bassleer C, Henrotin Y, Franchimont P. In-vitro evaluation of drugs proposed as chondroprotective agents. Intl J Tiss Reac. 14:1992;231-241.
30. Sandy J, Gamett D, Thompson V, Verscharen C. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J. 335:1998;59-66.
31. Rosselot G, Reginato A, Leach R. Development of a serum-free system to study the effect of growth hormone and insulin-like growth factor-I on cultured post-embryonic growth plate chondrocytes. In vitro Cell Dev. 28:1992;235-244.
32. Roach H. Long-term organ culture of embryonic chick femora: a system for investigating bone and cartilage formation at an intermediate level of organization. J Bone Miner Res. 5:1990;85-100.
33. Chandrasekhar S. Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem. 161:1987;103-110.
34. Homandberg G, Meyer R, Dong-lin X. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem. 267:1992;3597-3604.
35. Blanco F, Martin L. IL-1 induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res. 218:1995;319-325.
36. Dean D, Muniz O, Howell D. Association of collagenase and tissue inhibitor of metalloproteinase (TIMP) with hypertrophic cell enlargement in the growth plate. Matrix. 9:1989;366-375.
37. Hascall V, Kimura J. Proteoglycans: isolation and characterization. Methods Enzymol. 82:1982;769-799.
38. Castor C, Fremuth T, Furlong A. Hyaluronic acid and proteoglycan synthesis by lung fibroblasts in basal and activated states. In Vitro. 19:1983;462-470.
39. Caron J, Toppin D, Block J. Influence of polysulfated glycosaminoglycan on equine articular cartilage in explant culture. Amer J Vet Res. 52:1991;1622-1625.
40. SAS, SAS/STATÒ Software: Changes and Enhancements, Release 6.11, Cary, NC, 1996.
41. Stefanovic-Racic M, Watkins S, Kang R, Turner D, Evans C. Identification of inducible nitric oxide synthase in human osteoarthritic cartilage. Trans Orthop Res Soc. 21:1996;534.
42. Greenwald R, Golub L, Ramamurthy N, Chowdhury M, Moak S, Sora T. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. Bone. 22:1998;33-38.
43. Amin A, Attur M, Thakker G. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA. 93:1996;14,014-19.
44. McNamara P, Johnston S, Todhunter R. Slow-acting disease-modifying osteoarthritis agents. Vet Clin N Amer. 27:1997;863-877.
45. Setnikar I, Giacchetti C, Zanolo G. Pharmokinetics of glucosamine in the dog and in man. Drug Res. 36:1986;729-735.